Dr. Ali Shamseddine

Dr. Ali Shamseddine is currently a Professor of Clinical Medicine and Director of the Gastrointestinal/Genitourinary Cancer Program in the Haematology-Oncology Division and the Basile Cancer Institute at the American University of Beirut, in addition to being the Division Head for 17 years (Oct 2000–Nov 2017). Dr. Shamseddine graduated in 1981 and completed his training in medicine and medical oncology in 1988. Dr. Shamseddine served as the Chair of the Hospital Committee on Cancer for more than 10 years as well as the Director of the Tumur Registry at the Medical Center and the Data Management and Clinical Research Unit at NKBCI. He also served as the Vice President of the National Cancer Registry (NCR) from 2005 to 2010. Dr. Shamseddine is a member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO). His research interests include the epidemiology of cancer in Lebanon, breast cancer (epidemiology and platinum therapy), and gastrointestinal and prostatic cancers. In 2012, Dr. Shamseddine was elected as a Fellow of the Royal College of Physicians (FRCP London). In June 2020, he became a faculty member of the College of the European School of Oncology (ESCO). In October 2012, he was appointed the Director of the Data Base (2012–present) and Clinical Research Unit (2012–2017) of the Basile Cancer Institute at the American University of Beirut Medical Center.